WILLIAM HUDSON to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications WILLIAM HUDSON has written about Xenograft Model Antitumor Assays.
Connection Strength
0.091
-
Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targeting. Br J Cancer. 2025 Dec; 133(12):1802-1814.
Score: 0.046
-
Tobacco smoke exposure is a driver of altered oxidative stress response and immunity in head and neck cancer. J Transl Med. 2025 Apr 05; 23(1):403.
Score: 0.045